Abstract
Combining autologous bone graft and recombinant human bone morphogenetic protein-7 (BMP-7) to treat long-bone fracture aseptic atrophic nonunions theoretically could promote bone healing at higher rates than each of these grafting agents separately. We retrospectively reviewed prospectively collected data on patient general characteristics, clinical outcomes, and complications over 3 years to determine the healing rates and the incidence of complications and adverse events of this “graft expansion rationale.” There were 45 patients (32 male) with a median age of 43 years (range, 19–76 years). Minimum followup was 12 months (mean, 24.5 months; range, 12–65 months). There were seven humeral, 19 femoral, and 19 tibial nonunions. The median number of prior operations was two (range, 1–7). All fractures united. Clinical and radiographic union occurred within a median of 5 months (range, 3–14 months) and 6 months (range, 4–16 months), respectively. Thirty-nine (87%) patients returned to their preinjury occupation at a mean of 4.2 months (range, 3–6 months). The median visual analog scale pain score was 0.9 (range, 0–2.8; maximum 10), and the median functional score was 86 (range, 67–95; maximum 100) at the final followup. BMP-7 as a bone-stimulating agent combined with conventional autograft resulted in a nonunion healing rate of 100% in these 45 patients.
Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Arany L, Baranyai T, Mandi A, Kunkli F. Arteriographic studies in delayed-union and non-union of fractures. Radiol Diagn (Berl). 1980;21:673–681.
Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300–309.
Babhulkar S, Pande K. Nonunion of the diaphysis of long bones. Clin Orthop Relat Res. 2005;431:50–56.
Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000;371:10–27.
Bilic R, Simic P, Jelic M, Stern-Padovan R, Dodig D, van Meerdervoort HP, Martinovic S, Ivankovic D, Pecina M, Vukicevic S. Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis. Int Orthop. 2006;30:128–134.
Brand RA. 50 years ago in CORR: physiologic basis of bone-graft surgery Marshall R. Urist MD CORR 1953;1:207-216. Clin Orthop Relat Res. 2008;466:2015–2016.
Brinker MR. Nonunions: evaluation and treatment. In: Browner BD, Jupiter JB, Levine AM, Trafton PG, eds. Skeletal Trauma Basic Science Management and Reconstruction. 3rd Ed. Vol I. Philadelphia, PA: WB Saunders; 2003:507–604.
Brower RS, Vickroy NM. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine. 2008;33:E653–E655.
Calori GM, D’Avino M, Tagliabue L, Albisetti W, d’Imporzano M, Peretti G. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury. 2006;37(Suppl 3):S43–S50.
Cavadas PC, Landin L. Treatment of recalcitrant distal tibial nonunion using the descending genicular corticoperiosteal free flap. J Trauma. 2008;64:144–150.
Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res. 1995;313:8–18.
Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics. 1999;22:669–671.
Dahabreh Z, Dimitriou R, Giannoudis PV. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury. 2007;38:371–377.
Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 2002;143:1545–1553.
Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury. 2005;36(Suppl 4):S51–S59.
EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84:454–464.
Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83(Suppl 1):S151–S158.
Gamradt SC, Abe N, Bahamonde ME, Lee YP, Nelson SD, Lyons KM, Lieberman JR. Tracking expression of virally mediated BMP-2 in gene therapy for bone repair. Clin Orthop Relat Res. 2006;450:238–245.
Gerber A, Marti R, Jupiter J. Surgical management of diaphyseal humeral nonunion after intramedullary nailing: wave-plate fixation and autologous bone grafting without nail removal. J Shoulder Elbow Surg. 2003;12:309–313.
Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36(Suppl 3):S20–S27.
Giannoudis PV, Kanakaris NK, Einhorn TA. Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence. Osteoporos Int. 2007;18:1565–1581.
Giannoudis PV, Psarakis S, Kanakaris NK, Pape HC. Biological enhancement of bone healing with bone morphogenetic protein-7 at the clinical setting of pelvic girdle non-unions. Injury. 2007;38(Suppl 4):S43–48.
Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma. 1984;24:742–746.
Harwood PJ, Giannoudis PV. Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Expert Opin Drug Saf. 2005;4:75–89.
Johnson EE, Urist MR. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop Relat Res. 2000;371:61–74.
Kanakaris NK, Calori GM, Verdonk R, Burssens P, De Biase P, Capanna R, Vangosa LB, Cherubino P, Baldo F, Ristiniemi J, Kontakis G, Giannoudis PV. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury. 2008;39(Suppl 2):S83–S90.
Kanakaris NK, Giannoudis PV. The health economics of the treatment of long-bone non-unions. Injury. 2007;38(Suppl 2):S77–S84.
Kanakaris NK, Giannoudis PV. Clinical applications of bone morphogenetic proteins: current evidence. J Surg Orthop Adv. 2008;17:133–146.
Kanakaris NK, Paliobeis C, Manidakis N, Giannoudis PV. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury. 2007;38(Suppl 2):S65–S75.
Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13:77–86.
Makino T, Hak DJ, Hazelwood SJ, Curtiss S, Reddi AH. Prevention of atrophic nonunion development by recombinant human bone morphogenetic protein-7. J Orthop Res. 2005;23:632–638.
Pecina M, Haspl M, Jelic M, Vukicevic S. Repair of a resistant tibial non-union with a recombinant bone morphogenetic protein-7 (rh-BMP-7). Int Orthop. 2003;27:320–321.
Phieffer LS, Goulet JA. Delayed unions of the tibia. J Bone Joint Surg Am. 2006;88:206–216.
Praemer A, Furner S, Rice DP, eds. Musculoskeletal Conditions in the United States. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1999.
Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am. 2001;83(Suppl 1):S1–S6.
Ring D, Barrick WT, Jupiter JB. Recalcitrant nonunion. Clin Orthop Relat Res. 1997;340:181–189.
Ronga M, Baldo F, Zappala G, Cherubino P. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients. Injury. 2006;37(Suppl 3):S51–S56.
Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am. 2001;83:803–816.
Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2:175–184.
Sen MK, Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? Injury. 2007;38(Suppl 1):S75–S80.
Souter WA. Autogenous cancellous strip grafts in the treatment of delayed union of long bone fractures. J Bone Joint Surg Br. 1969;51:63–75.
Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJ. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am. 2005;87:1367–1378.
Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: which are the important molecules? Injury. 2007;38(Suppl 1):S11–S25.
Tzioupis C, Giannoudis PV. Prevalence of long-bone non-unions. Injury. 2007;38(Suppl 2):S3–S9.
Urban RM, Turner TM, Hall DJ, Inoue N, Gitelis S. Increased bone formation using calcium sulfate-calcium phosphate composite graft. Clin Orthop Relat Res. 2007;459:110–117.
Urist MR. Bone: formation by autoinduction. Science. 1965;150:893–899.
Weber BG, Brunner C. The treatment of nonunions without electrical stimulation. Clin Orthop Relat Res. 1981;161:24–32.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242:1528–1534.
Wu CC. Bone grafting techniques in treating fracture nonunion. Chang Gung Med J. 2000;23:319–330.
Yeh LC, Adamo ML, Olson MS, Lee JC. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology. 1997;138:4181–4190.
Yeh LC, Tsai AD, Lee JC. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem. 2002;87:292–304.
Zaslav KR, Meinhard BP. Management of resistant pseudarthrosis of long bones. Clin Orthop Relat Res. 1988;233:234–242.
Zimmermann G, Moghaddam A, Wagner C, Vock B, Wentzensen A. Clinical experience with bone morphogenetic protein 7 (BMP 7) in nonunions of long bones [in German]. Unfallchirurg. 2006;109:528–537.
Zimmermann G, Muller U, Loffler C, Wentzensen A, Moghaddam A. Therapeutic outcome in tibial pseudarthrosis: bone morphogenetic protein 7 (BMP-7) versus autologous bone grafting for tibial fractures [in German]. Unfallchirurg. 2007;110:931–938.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
Each author certifies that his or her institution has approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
This work was performed at Leeds General Infirmary and Middlesbrough General Hospital.
About this article
Cite this article
Giannoudis, P.V., Kanakaris, N.K., Dimitriou, R. et al. The Synergistic Effect of Autograft and BMP-7 in the Treatment of Atrophic Nonunions. Clin Orthop Relat Res 467, 3239–3248 (2009). https://doi.org/10.1007/s11999-009-0846-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-009-0846-2